Predicting response and outcome of metastatic breast cancer anti-estrogen therapy

Details for Australian Patent Application No. 2004294527 (hide)

Owner Erasmus MC

Inventors Klijn, Joannes G.M.; Janssen, Maurice P.H.M.; Berns, Petronella M.J.J.; Foekens, John A.

Agent Spruson & Ferguson

Pub. Number AU-A-2004294527

PCT Pub. Number WO2005/054510

Priority 60/527,608 05.12.03 US

Filing date 3 December 2004

Wipo publication date 16 June 2005

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer

Event Publications

27 July 2006 PCT application entered the National Phase

  PCT publication WO2005/054510 Priority application(s): WO2005/054510

21 April 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004294547-Polymorphic CD24 genotypes that are predictive of multiple sclerosis risk and progression

2004294526-Method for diagnosing diseases based on levels of anti-glycan antibodies